TY - CHAP M1 - Book, Section TI - Overview of Robotics in Thoracic Surgery A1 - Lee, Fred A1 - Groth, Shawn S. A2 - Sugarbaker, David J. A2 - Bueno, Raphael A2 - Burt, Bryan M. A2 - Groth, Shawn S. A2 - Loor, Gabriel A2 - Wolf, Andrea S. A2 - Williams, Marcia A2 - Adams, Ann PY - 2020 T2 - Sugarbaker’s Adult Chest Surgery, 3e AB - Adding to the ever-growing armamentarium of minimally invasive surgical technology, robotic devices were first introduced in 1985 when an industrial robotic arm was modified to perform a stereotactic brain biopsy.1 With the only U.S. Food and Drug Administration (FDA)-approved surgical system currently on the market, Intuitive Surgical Inc. (Sunnyvale, CA) launched the da Vinci Surgical System in 1999 and it was cleared by the FDA for laparoscopic surgery in 2000.2 Although Intuitive’s initial market efforts were directed toward minimally invasive cardiac surgery, its applications have expanded, initially toward urologic and gynecologic surgery and now toward the full gamut of laparoscopic and thoracoscopic procedures. The robotic platform is an alternative approach for all operations performed by standard thoracoscopy and laparoscopy. Lobectomy3 (including 3-arm4 and 4-arm approaches5), chest wall resection with robotic assistance for the parenchymal dissection, removal of mediastinal masses (including thymectomy),6 diaphragm plication,7 anti-reflux procedures,8 and minimally invasive esophagectomy9,10 have all been described in the thoracic robotic surgical literature.11 SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/03/29 UR - accesssurgery.mhmedical.com/content.aspx?aid=1170416659 ER -